Am I a Candidate for Thyroid RFA? The Criteria That Decide
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Radiofrequency ablation (RFA) is an effective non-surgical treatment for thyroid nodules. It is not right for every patient or every nodule. The candidacy criteria are specific, and applying them correctly is what separates a good RFA outcome from a wrong-procedure decision. This article walks through exactly who is and who is not a candidate, and the questions to ask before scheduling.
RFA uses a thin needle electrode placed directly into the thyroid nodule under ultrasound guidance. The needle delivers radiofrequency energy that heats and destroys the tissue. Over months, the body absorbs the dead tissue, the nodule shrinks substantially, and most patients see 50 to 80% volume reduction by 12 months. The thyroid itself is preserved. The procedure is outpatient, takes 30 minutes under local anesthesia, and most patients return to normal activity within a day.
The procedure works well when applied to the right nodule in the right patient. It is the wrong choice for several specific situations.
Who Is a Good Candidate
-
Nodule confirmed benign biopsy: At least one (ideally two) Bethesda II biopsies confirming the nodule is benign.
-
Symptomatic or cosmetically bothersome nodule: Pressure symptoms, visible neck swelling, voice changes, swallowing difficulty, or appearance concern.
-
Nodule size 1 to 4 cm in most cases: Small nodules generally do not require treatment; very large nodules may be better treated surgically.
-
Nodule located away from critical structures: Some distance from the recurrent laryngeal nerve, parathyroid glands, and trachea so that energy can be delivered safely.
-
Predominantly solid or mixed nodule: Cystic nodules may be better treated with ethanol ablation; predominantly solid or mixed nodules are typical RFA candidates.
-
Patient preference for non-surgical treatment: When surgery is the alternative, choosing RFA means weighing the trade-offs and accepting the recovery profile.
Who Is Not a Candidate
| Situation | Why RFA Is Not Right |
|---|---|
| Cancer or suspicious biopsy (Bethesda IV, V, VI) | RFA does not provide tissue diagnosis or address lymph nodes. Surgery is the standard. |
| Indeterminate biopsy (Bethesda III) without further evaluation | Cancer cannot be ruled out yet. Molecular testing or repeat biopsy comes first. |
| Substernal extension into the chest | Out of reach of the needle. Surgery is required. |
| Nodule immediately adjacent to nerve, trachea, or esophagus | Heat injury risk to critical structures. Selected experienced centers use special techniques, but most do not treat in this scenario. |
| Very large nodule (typically over 5 cm) | Limited shrinkage of very large nodules; surgery often preferred. |
| Multiple growing nodules | Treating one nodule may not address the underlying issue. Surgical resection of the whole gland may be more efficient. |
| Pregnancy | Generally deferred until after pregnancy. |
⚕ Clinical note The most important screening step for RFA candidacy is making sure the biopsy is genuinely benign. Some centers will not proceed without two separate Bethesda II results, particularly for nodules with any imaging features that are not entirely reassuring. The reason is that RFA destroys the tissue without providing a diagnosis. If a cancer is hiding in a nodule with one benign biopsy, RFA could obscure the diagnosis and delay appropriate cancer treatment.
Special Cases Where RFA Is Increasingly Used
-
Toxic (hot) nodules: Autonomously functioning nodules causing hyperthyroidism. RFA can destroy the overactive tissue and resolve the hyperthyroidism in many patients. An alternative to surgery for selected cases.
-
Predominantly cystic nodules: Ethanol ablation is typically the first-line procedure, but RFA can be used when ethanol has failed or for mixed nodules with a significant solid component.
-
Recurrent benign nodules: A nodule that has grown back after surgery on the other lobe, in a patient who wants to preserve the remaining thyroid, may be appropriate for RFA.
-
Selected papillary microcarcinoma: In some centers internationally, RFA is being investigated for very small papillary thyroid cancers. This is not yet standard practice in the United States, but is becoming more common.
⚕ Clinical note: RFA is increasingly used at specialty centers in the United States but is still less widely available than thyroid surgery. The procedure depends on the experience of the operator and the equipment available. A patient who is a candidate but cannot easily reach an experienced RFA center may be better served by an experienced thyroid surgeon nearby than by traveling for RFA. Both decisions are reasonable.
Questions to Ask Before Scheduling RFA
-
How many thyroid RFAs do you perform per year? Volume matters as much for RFA as for surgery.
-
What complication rates do you publish? The relevant rates are nerve injury, hematoma, and skin burn.
-
What is the expected volume reduction at 6 and 12 months? It should be 50 to 80% in most cases.
-
What happens if the nodule does not shrink enough? A second RFA session is reasonable; some patients ultimately convert to surgery.
-
Do you perform RFA under hydrodissection technique? A technique to protect adjacent structures by injecting fluid between the nodule and nearby nerves.
The Bottom Line
RFA is an effective treatment for benign symptomatic thyroid nodules in carefully selected patients. The right candidate has a confirmed benign biopsy, a symptomatic or cosmetically bothersome nodule, favorable anatomy, and a moderate size. RFA is not appropriate for cancer, indeterminate biopsy results, substernal nodules, or nodules adjacent to critical structures. Centers with high RFA volume and clear outcomes data are the right places to seek the procedure.
If you are interested in RFA, confirm with your physician that you meet the candidacy criteria and consult with a center that performs the procedure regularly before making a decision.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Options Besides Surgery series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →



